Huxley Medical

What Huxley Medical does

Huxley Medical is a privately held medical device company headquartered in Atlanta, Georgia, founded in 2019. The company develops and commercializes SANSA, a cellular-enabled chest-worn home sleep apnea test (HSAT) that captures nine physiologic channels without wires, belts, finger probes, or nasal cannulas. SANSA is differentiated as the only diagnostic service capable of assessing obstructive sleep apnea, central sleep apnea, and ECG from a single patch device, with FDA 510(k) clearances spanning HSAT (August 2024), cellular connectivity (February 2025), central sleep apnea detection (December 2025), and diagnostic ECG for arrhythmia detection including atrial fibrillation (December 2025).

The underlying platform combines a disposable patch with the Huxley HUB, a HIPAA-compliant cloud-native portal featuring FDA-cleared autoscoring at 3% and 4% desaturation thresholds, real-time epoch-by-epoch over-scoring, customizable report templates, and EHR integration. Eleven granted patents cover the patch design, PPG sensors, SpO2 detection with skin tone compensation, and biometric data processing algorithms. The device uploads data automatically over integrated cellular, eliminating the need for smartphone, Bluetooth, or app pairing. Clinical validation published in Frontiers in Neurology and SLEEP demonstrated 95% sensitivity for sleep apnea, 99% accuracy for central sleep apnea, and ±1 AHI mean difference versus in-lab polysomnography.

Huxley sells exclusively through healthcare providers via three zero-upfront-cost service models: SANSA Express (direct-to-patient shipping with Huxley-managed logistics), SANSA GO (point-of-care dispensing in clinic), and SANSA 360 (fully managed in-network virtual pathway with board-certified sleep providers). Target customers include sleep labs, cardiology clinics, and primary care practices. Providers interpret studies and bill insurance; Huxley manages device logistics, 24/7/365 patient support, and platform access. Capital has been raised through multiple SEC Form D exempt securities offerings and NSF grants, with the company having engaged a capital partner for up to $15 million in financing announced in April 2026.

Name

Huxley Medical

Legal name

Huxley Medical, Inc.

Website

https://huxleymed.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Huxley Medical is an Atlanta-based medical device company that develops SANSA, a cellular-enabled chest-worn home sleep apnea diagnostic monitor with integrated ECG. It sells the FDA-cleared device plus cloud platform to sleep labs, cardiology clinics, and primary care practices via three zero-upfront-cost service models.

Ownership category

akta.pro rank

Product category

Sleep Apnea Diagnostic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)

akta.pro secondary industries

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)

Keywords

• Home sleep apnea testing
• Medical diagnostic devices
• Cardiac monitoring systems
• Sleep medicine diagnostics
• Physiologic monitoring platforms

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Testing Services: Huxley provides home sleep apnea testing devices and services to healthcare providers who interpret results and bill insurance. Providers receive zero upfront costs with Huxley managing device logistics and patient support.
2. SANSA 360 Managed Pathway: Fully managed in-network virtual pathway where Huxley handles patient testing and reviews results with board-certified sleep provider. Provider prescribes treatment options.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Huxley Medical designs, manufactures, and distributes the SANSA diagnostic platform — a cellular-enabled, chest-worn home sleep apnea test that captures nine physiologic channels without wires, belts, finger probes, or nasal cannulas and uploads data automatically over integrated cellular. The device is delivered to healthcare providers through three service models (SANSA Express, SANSA GO, and SANSA 360) with zero upfront costs, while the Huxley HUB cloud platform provides FDA-cleared autoscoring, ECG arrhythmia detection, central sleep apnea detection, hypoxic burden analysis, and EHR integration.

Product overview

Huxley Medical offers SANSA, a unified diagnostic service platform for home sleep apnea testing. The core SANSA device is a cellular-enabled chest-worn monitor that captures nine physiologic channels to assess obstructive sleep apnea, central sleep apnea, and ECG from a single patch. Three service delivery models serve different clinical workflows: SANSA Express (direct-to-patient logistics managed by Huxley), SANSA GO (point-of-care clinic dispensing), and SANSA 360 (fully managed virtual care pathway). The Huxley HUB cloud platform provides auto-scoring, real-time analytics, customizable reporting, and EHR integration across all service models. All models include 24/7/365 patient support.

Differentiator

Problem solved

Functional benefit

Brands

• SANSA: FDA-cleared diagnostic service and home sleep apnea test that assesses obstructive sleep apnea, central sleep apnea, and ECG from a single cellular-enabled monitor. Includes SANSA Express, SANSA GO, and SANSA 360 service models.
• SANSA Express
• SANSA GO
• SANSA 360
• Huxley HUB

Products and services

• SANSA Home Sleep Apnea Test A cellular-enabled chest-worn diagnostic monitor and home sleep apnea test for healthcare providers that captures nine FDA-cleared physiologic channels without wires, belts, finger probes, or nasal cannulas and uploads data automatically over integrated cellular.
• SANSA Express

Quantifiable outcome

• 95% sensitivity for sleep apnea (validated against polysomnography)
• +6 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Compumedics: Compumedics manufactures the Somte and other PSG/HSAT devices used in sleep labs and research settings. Comparable to Huxley as a competitor for sleep lab HSAT contracts, with broader PSG heritage and global reach but no cellular-enabled wire-free chest patch equivalent to SANSA.
• Itamar Medical (ZOLL Itamar): Itamar Medical, now part of ZOLL Medical, sells the WatchPAT family of home sleep apnea tests - the most established HSAT competitor to SANSA. Both companies target sleep specialists and primary care with simplified at-home diagnostic workflows, though WatchPAT uses a finger-based peripheral arterial tone sensor versus Huxley's chest-worn patch with integrated cellular.
• Nox Medical: Nox Medical manufactures the Nox T3 and related HSAT/PSG systems used by sleep labs and home testing providers globally. Like Huxley, Nox competes in wire-free ambulatory sleep recording with cloud-based analysis, but retains a more traditional multi-sensor architecture rather than SANSA's single-patch cellular design.
• CleveMed: CleveMed markets the SleepScout and Sapphire HSAT systems to sleep specialists and primary care providers. Direct competitor to SANSA in the US home sleep apnea testing market, with a focus on simplified ambulatory recording, though without Huxley's integrated cellular upload and ECG arrhythmia detection capabilities.

Emerging players

• Withings: Withings offers the Sleep Analyzer and ScanWatch products combining sleep apnea screening with ECG arrhythmia detection - mirroring Huxley's sleep-plus-cardiac value proposition in a consumer/over-the-counter distribution model. Comparable as an adjacent emerging competitor pursuing combined sleep and cardiac monitoring, though targeting consumers rather than Huxley's provider channel.
• Ectosense (NightOwl): Ectosense offers the NightOwl, a cloud-based HSAT using a fingertip sensor with smartphone-driven workflow. Comparable to Huxley as an emerging, tech-forward HSAT competitor focused on simplified home testing and remote scoring, though NightOwl's fingertip architecture competes more on convenience than Huxley's chest-worn multi-channel approach.
• SleepImage: SleepImage provides a cloud-based cardiopulmonary coupling sleep assessment platform used for sleep apnea diagnosis and management. Comparable to Huxley's Huxley HUB in delivering cloud-native, FDA-cleared autoscoring and analytics to clinicians, and emerging as a software-led alternative in the HSAT ecosystem, though without Huxley's integrated hardware patch.
• Belun Technology: Belun Technology markets the Belun Ring and other wearable sleep apnea monitoring devices for home and clinical use. Emerging player comparable to Huxley in targeting simplified, patient-friendly sleep apnea screening, though using a ring form factor rather than SANSA's chest patch and with a different reimbursement / clinical positioning.

Broad incumbents

• ResMed: ResMed is the global leader in sleep apnea therapy (CPAP/APAP) and sells home sleep testing solutions through its residential care business. As a broad incumbent, ResMed competes with Huxley for HSAT volume at sleep labs and primary care, and benefits from deep clinical relationships, large sales forces, and bundled CPAP-plus-diagnostics economics that Huxley cannot match at current scale.
• Philips Respironics: Philips offers the Alice NightOne and other HSAT/PSG devices alongside its dominant CPAP/APAP franchise. Comparable as a broad incumbent competitor for both sleep lab and home testing accounts, with the scale to bundle diagnostic and therapy economics - representing the most significant competitive threat to Huxley's enterprise sales motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/huxley-medical-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds7 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Huxley Medical